RESPONSE BIOMEDICAL , founded in 1991. Develops, manufactures and markets the RAMP ® system. The RAMP® System is an immunoassay platform that provides information in minutes. Rapid diagnostic platform that delivers lab-quality performance for efficient patient management in acute care settings. 100% of RAMP® tests and instruments are made in Canada. It is marketed in 35 countries and continues to expand.
A high-performance multi-port laboratory reader
True point-of-care testing solution. Completely portable and lightweight reader.
Each cartridge is a quantitative immunochromatographic test that determines the concentration of a cardiac marker in EDTA whole blood, or an infectious disease – including Sepsis.
RAMP® Test Panel
COVID-19 Antigen Test
TROPONIN I (TnI)
Biomarker of pregnancy (b-hCG)
The RAMP® Platform
offers a comprehensive solution for Hospitals, Critical Care Units and Laboratories – to perform IVD diagnostic tests – on site, with the precision of large laboratory analyzers and the speed and simplicity of use of Point of Care equipment.